1. Home
  2. RMTI vs CTSO Comparison

RMTI vs CTSO Comparison

Compare RMTI & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rockwell Medical Inc.

RMTI

Rockwell Medical Inc.

N/A

Current Price

$6.00

Market Cap

29.1M

Sector

Health Care

ML Signal

N/A

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

SELL

Current Price

$4.52

Market Cap

23.9M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RMTI
CTSO
Founded
1994
1997
Country
United States
United States
Employees
300
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
29.1M
23.9M
IPO Year
2022
2008

Fundamental Metrics

Financial Performance
Metric
RMTI
CTSO
Price
$6.00
$4.52
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$20.00
★ $32.50
AVG Volume (30 Days)
★ 22.2K
22.2K
Earning Date
11-12-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 65.79
EPS
★ N/A
N/A
Revenue
★ $69,258,000.00
$22,503,908.00
Revenue This Year
$5.09
$2.14
Revenue Next Year
$8.02
$16.24
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 48.53
52 Week Low
$0.55
$0.30
52 Week High
$8.90
$7.44

Technical Indicators

Market Signals
Indicator
RMTI
CTSO
Relative Strength Index (RSI) 33.77 46.03
Support Level $0.78 $2.88
Resistance Level $6.14 $7.20
Average True Range (ATR) 0.59 0.79
MACD -0.13 -0.07
Stochastic Oscillator 2.02 15.43

Price Performance

Historical Comparison
RMTI
CTSO

About RMTI Rockwell Medical Inc.

Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.

About CTSO Cytosorbents Corporation

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery. CytoSorbent's proprietary blood purification technologies are based on biocompatible, high-porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. CytoSorbent's technologies are used in several broad applications. Specifically, two important applications are: the removal of blood thinners during and after cardiothoracic surgery to reduce the risk of severe bleeding, and the removal of inflammatory agents and toxins in common critical illnesses that can cause massive inflammation, organ failure, and patient death. Geographically, in the USA, Germany, and Others.

Share on Social Networks: